Baterna, Serenio A.
HRN: 21-59-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/19/2022
07/26/2022
IV
600mg
Q6hours
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes